These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 16276044)

  • 1. [Toll-like receptor].
    Takeda K
    Nihon Rinsho Meneki Gakkai Kaishi; 2005 Oct; 28(5):309-17. PubMed ID: 16276044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptors in innate immunity.
    Takeda K; Akira S
    Int Immunol; 2005 Jan; 17(1):1-14. PubMed ID: 15585605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [TIR domain--containing adaptors regulate TLR-mediated signaling pathways].
    Yamamoto M; Akira S
    Nihon Rinsho; 2004 Dec; 62(12):2197-203. PubMed ID: 15597785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution and integration of innate immune recognition systems: the Toll-like receptors.
    Takeda K
    J Endotoxin Res; 2005; 11(1):51-5. PubMed ID: 15826379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primers on molecular pathways: lipopolysaccharide signaling - potential role in pancreatitis and pancreatic cancer.
    Del Pozo JL
    Pancreatology; 2010; 10(2-3):114-8. PubMed ID: 20460943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signalling of toll-like receptors.
    Brikos C; O'Neill LA
    Handb Exp Pharmacol; 2008; (183):21-50. PubMed ID: 18071653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR signaling pathways.
    Takeda K; Akira S
    Semin Immunol; 2004 Feb; 16(1):3-9. PubMed ID: 14751757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TIR domain-containing adaptors define the specificity of TLR signaling.
    Yamamoto M; Takeda K; Akira S
    Mol Immunol; 2004 Feb; 40(12):861-8. PubMed ID: 14698224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptors are key participants in innate immune responses.
    Arancibia SA; Beltrán CJ; Aguirre IM; Silva P; Peralta AL; Malinarich F; Hermoso MA
    Biol Res; 2007; 40(2):97-112. PubMed ID: 18064347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of Toll-interleukin 1 receptor mediated signaling.
    Li X; Qin J
    J Mol Med (Berl); 2005 Apr; 83(4):258-66. PubMed ID: 15662540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
    Horng T; Barton GM; Flavell RA; Medzhitov R
    Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signalling, sorting and scaffolding adaptors for Toll-like receptors.
    Luo L; Lucas RM; Liu L; Stow JL
    J Cell Sci; 2019 Dec; 133(5):. PubMed ID: 31889021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptors.
    Takeda K; Akira S
    Curr Protoc Immunol; 2015 Apr; 109():14.12.1-14.12.10. PubMed ID: 25845562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
    Cui J; Chen Y; Wang HY; Wang RF
    Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling.
    O'Neill LA; Bowie AG
    Nat Rev Immunol; 2007 May; 7(5):353-64. PubMed ID: 17457343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor signaling pathways--therapeutic opportunities.
    Zhu J; Mohan C
    Mediators Inflamm; 2010; 2010():781235. PubMed ID: 20981241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
    Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S
    J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway.
    Lang T; Lo C; Skinner N; Locarnini S; Visvanathan K; Mansell A
    J Hepatol; 2011 Oct; 55(4):762-9. PubMed ID: 21334391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling of apoptosis through TLRs critically involves toll/IL-1 receptor domain-containing adapter inducing IFN-beta, but not MyD88, in bacteria-infected murine macrophages.
    Ruckdeschel K; Pfaffinger G; Haase R; Sing A; Weighardt H; Häcker G; Holzmann B; Heesemann J
    J Immunol; 2004 Sep; 173(5):3320-8. PubMed ID: 15322195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.